CD4+CD25+ regulatory T cells resist a novel form of CD28- and Fas-dependent p53-induced T cell apoptosis

Journal of Immunology

Volumn 184, Issue 1, 2010, Pages 94-104

  Singh, Nagendra ^a   Yamamoto, Mutsumi ^a,b   Takami, Mariko ^a,b   Seki, Yoichi ^a,b   Takezaki, Mayuko ^a   Mellor, Andrew L ^a   Iwashima, Makio ^a,b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIBODY; FAS ANTIGEN; FAS LIGAND; PROTEIN P53; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CULTURE; CELL DEATH; CELL EXPANSION; CELL GROWTH; CONTROLLED STUDY; GENE EXPRESSION; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TUMOR SUPPRESSOR GENE; ANIMAL; CD4+ T LYMPHOCYTE; CYTOLOGY; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; T LYMPHOCYTE SUBPOPULATION; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD28; ANTIGENS, CD95; APOPTOSIS; BLOTTING, WESTERN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; MICE; MICE, KNOCKOUT; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 73949142597     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900753     Document Type: Article

References (51)

1. Belkaid, Y. 2008. Role of Foxp3-positive regulatory T cells during infection. Eur. J. Immunol. 38: 918-921.
2. Sakaguchi, S., T. Yamaguchi, T. Nomura, and M. Ono. 2008. Regulatory T cells and immune tolerance. Cell 133: 775-787.
3. Read, S., V. Malmström, and F. Powrie. 2000. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med. 192: 295-302.
4. Collison, L. W., C. J. Workman, T. T. Kuo, K. Boyd, Y. Wang, K. M. Vignali, R. Cross, D. Sehy, R. S. Blumberg, and D. A. Vignali. 2007. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450: 566-569.
5. Pandiyan, P., L. Zheng, S. Ishihara, J. Reed, and M. J. Lenardo. 2007. CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat. Immunol. 8: 1353-1362.
6. Onishi, Y., Z. Fehervari, T. Yamaguchi, and S. Sakaguchi. 2008. Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc. Natl. Acad. Sci. USA 105: 10113-10118.
7. Ochs, H. D., S. F. Ziegler, and T. R. Torgerson. 2005. FOXP3 acts as a rheostat of the immune response. Immunol. Rev. 203: 156-164.
8. Krammer, P. H., R. Arnold, and I. N. Lavrik. 2007. Life and death in peripheral T cells. Nat. Rev. Immunol. 7: 532-542.
9. Green, D. R., N. Droin, and M. Pinkoski. 2003. Activation-induced cell death in T cells. Immunol. Rev. 193: 70-81.
10. Lenardo, M. J. 1991. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 353: 858-861.
11. Zhang, J., T. Bárdos, Q. Shao, J. Tschopp, K. Mikecz, T.T. Glant, and A. Finnegan. 2003. IL-4 potentiates activated T cell apoptosis via an IL-2-dependentmechanism. J. Immunol. 170: 3495-3503. (Pubitemid 36359215)
12. Banda, N. K., J. Bernier, D. K. Kurahara, R. Kurrle, N. Haigwood, R. P. Sekaly, and T. H. Finkel. 1992. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J. Exp. Med. 176: 1099-1106.
13. Newell, M. K., L. J. Haughn, C. R. Maroun, and M. H. Julius. 1990. Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen. Nature 347: 286-289. (Pubitemid 120015045)
14. Scheipers, P., and H. Reiser. 1998. Fas-independent death of activated CD4(+) T lymphocytes induced by CTLA-4 crosslinking. Proc. Natl. Acad. Sci. USA 95: 10083-10088.
15. Radvanyi, L. G., Y. Shi, H. Vaziri, A. Sharma, R. Dhala, G. B. Mills, and R. G. Miller. 1996. CD28 costimulation inhibits TCR-induced apoptosis during a primary T cell response. J. Immunol. 156: 1788-1798. (Pubitemid 26069311)
16. Okkenhaug, K., L. Wu, K. M. Garza, J. La Rose, W. Khoo, B. Odermatt, T. W. Mak, P. S. Ohashi, and R. Rottapel. 2001. A point mutation in CD28 distinguishes proliferative signals from survival signals. Nat. Immunol. 2: 325-332.
17. Boehme, S. A., and M. J. Lenardo. 1996. TCR-mediated death of mature T lymphocytes occurs in the absence of p53. J. Immunol. 156: 4075-4078.
18. Simelyte, E., S. Rosengren, D. L. Boyle, M. Corr, D. R. Green, and G. S. Firestein. 2005. Regulation of arthritis by p53: critical role of adaptive immunity. Arthritis Rheum. 52: 1876-1884.
19. Okuda, Y., M. Okuda, and C. C. Bernard. 2003. Regulatory role of p53 in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 135: 29-37.
20. Zheng, S. J., S. E. Lamhamedi-Cherradi, P. Wang, L. Xu, and Y. H. Chen. 2005. Tumor suppressor p53 inhibits autoimmune inflammation and macrophage function. Diabetes 54: 1423-1428.
21. Bouillet, P., D. Metcalf, D. C. Huang, D. M. Tarlinton, T. W. Kay, F. Köntgen, J. M. Adams, and A. Strasser. 1999. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286: 1735-1738.
22. Balomenos, D., J. Martín-Caballero, M. I. García, I. Prieto, J. M. Flores, M. Serrano, and C. Martínez-A. 2000. The cell cycle inhibitor p21 controls Tcell proliferation and sex-linked lupus development. Nat. Med. 6: 171-176.
23. Liu, L., E. Tran, Y. Zhao, Y. Huang, R. Flavell, and B. Lu. 2005. Gadd45 β and Gadd45 γ are critical for regulating autoimmunity. J. Exp. Med. 202: 1341-1347.
24. Salvador, J. M., M. C. Hollander, A. T. Nguyen, J. B. Kopp, L. Barisoni, J. K. Moore, J. D. Ashwell, and A. J. Fornace Jr. 2002. Mice lacking the p53-effector gene Gadd45a develop a lupus-like syndrome. Immunity 16: 499-508.
25. Singh, N., Y. Seki, M. Takami, B. Baban, P. R. Chandler, D. Khosravi, X. Zheng, M. Takezaki, J. R. Lee, A. L. Mellor, et al. 2006. Enrichment of regulatory CD4(+) CD25(+) T cells by inhibition of phospholipase D signaling. Nat. Methods 3: 629-636.
26. Tang, Q., K. J. Henriksen, M. Bi, E. B. Finger, G. Szot, J. Ye, E. L. Masteller, H. McDevitt, M. Bonyhadi, and J. A. Bluestone. 2004. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199: 1455-1465.
27. Refaeli, Y., L. Van Parijs, C. A. London, J. Tschopp, and A. K. Abbas. 1998. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 8: 615-623.
28. Speiser, D. E., E. Sebzda, T. Ohteki, M. F. Bachmann, K. Pfeffer, T. W. Mak, and P. S. Ohashi. 1996. Tumor necrosis factor receptor p55 mediates deletion of peripheral cytotoxic T lymphocytes in vivo. Eur. J. Immunol. 26: 3055-3060.
29. Sytwu, H. K., R. S. Liblau, and H. O. McDevitt. 1996. The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 5: 17-30.
30. Zheng, L., G. Fisher, R. E. Miller, J. Peschon, D. H. Lynch, and M. J. Lenardo. 1995. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377: 348-351.
31. Vogelstein, B., D. Lane, and A. J. Levine. 2000. Surfing the p53 network. Nature 408: 307-310.
32. Lu, L., S. Qian, P. A. Hershberger, W. A. Rudert, D. H. Lynch, and A. W. Thomson. 1997. Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation. J. Immunol. 158: 5676-5684. (Pubitemid 127483971)
33. Süss, G., and K. Shortman. 1996. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J. Exp. Med. 183: 1789-1796.
34. Owen-Schaub, L. B., W. Zhang, J. C. Cusack, L. S. Angelo, S. M. Santee, T. Fujiwara, J. A. Roth, A. B. Deisseroth, W. W. Zhang, E. Kruzel, et al. 1995. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol. Cell. Biol. 15: 3032-3040.
35. Brooks, C. L., and W. Gu. 2006. p53 ubiquitination: Mdm2 and beyond. Mol. Cell 21: 307-315.
36. Caspari, T. 2000. How to activate p53. Curr. Biol. 10: R315-R317.
37. Arias, C. F., A. Ballesteros-Tato, M. I. García, J. Martín-Caballero, J. M. Flores, C. Martínez-A, and D. Balomenos. 2007. p21CIP1/WAF1 controls proliferation of activated/memory T cells and affects homeostasis and memory T cell responses. J. Immunol. 178: 2296-2306.
38. Hutcheson, J., J. C. Scatizzi, A. M. Siddiqui, G. K. Haines 3rd, T. Wu, Q. Z. Li, L. S. Davis, C. Mohan, and H. Perlman. 2008. Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity. Immunity 28: 206-217.
39. Zheng, S. J., and Y. H. Chen. 2003. TRAIL, Bim, and thymic-negative selection. Immunol. Res. 28: 295-301.
40. Chen, D., and Q. Zhou. 2004. Caspase cleavage of BimEL triggers a positive feedback amplification of apoptotic signaling. Proc. Natl. Acad. Sci. USA 101: 1235-1240.
41. Sandalova, E., C. H. Wei, M. G. Masucci, and V. Levitsky. 2004. Regulation of expression of Bcl-2 protein family member Bim by T cell receptor triggering. Proc. Natl. Acad. Sci. USA 101: 3011-3016.
42. Salomon, B., and J. A. Bluestone. 2001. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu. Rev. Immunol. 19: 225-252.
43. Jenkins, M. K., P. S. Taylor, S. D. Norton, and K. B. Urdahl. 1991. CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. J. Immunol. 147: 2461-2466.
44. Lindstein, T., C. H. June, J. A. Ledbetter, G. Stella, and C. B. Thompson. 1989. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244: 339-343.
45. Fraser, J. D., B. A. Irving, G. R. Crabtree, and A. Weiss. 1991. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 251: 313-316.
46. Noel, P. J., L. H. Boise, J. M. Green, and C. B. Thompson. 1996. CD28 costimulation prevents cell death during primary T cell activation. J. Immunol. 157: 636-642. (Pubitemid 26231365)
47. Boise, L. H., A. J. Minn, P. J. Noel, C. H. June, M. A. Accavitti, T. Lindsten, and C. B. Thompson. 1995. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity 3: 87-98.
48. Bromley, S. K., A. Iaboni, S. J. Davis, A. Whitty, J. M. Green, A. S. Shaw, A. Weiss, and M. L. Dustin. 2001. The immunological synapse and CD28-CD80 interactions. Nat. Immunol. 2: 1159-1166.
49. Wetzel, S. A., T. W. McKeithan, and D. C. Parker. 2002. Live-cell dynamics and the role of costimulation in immunological synapse formation. J. Immunol. 169: 6092-6101. (Pubitemid 36903452)
50. Maas, K., M. Westfall, J. Pietenpol, N. J. Olsen, and T. Aune. 2005. Reduced p53 in peripheral blood mononuclear cells from patients with rheumatoid arthritis is associated with loss of radiation-induced apoptosis. Arthritis Rheum. 52: 1047-1057.
51. Deng, X., A. Ljunggren-Rose, K. Maas, and S. Sriram. 2005. Defective ATMp-53-mediated apoptotic pathway in multiple sclerosis. Ann. Neurol. 58: 577-584.